Find more information about SUBLOCADE dosing and administration for patients with moderate to severe OUD. See Safety Info, PI, & Boxed Warning.

Clean the injection site well with an alcohol swab. To avoid irritation, rotate injection sites following a pattern similar to the illustration. Record the location of the injection to ensure that a diferent site is …

SUBLOCADE is for healthcare provider preparation and administration only. (2.1) SUBLOCADE is administered only by subcutaneous injection in the abdomen, thigh, buttock, or back of the upper …

After your first two 300 mg injections of SUBLOCADE, you'll receive ongoing injections once a month (there will be at least 26 days between each injection). The recommended monthly dose of …

Jan 8, 2026 · Detailed dosage guidelines and administration information for Sublocade (buprenorphine). Includes dose adjustments, warnings and precautions.

Administering Sublocade injections requires precision and knowledge to ensure effective treatment outcomes. This comprehensive guide will delve into the details of giving Sublocade injections, …

The manufacturer recommends initiating SUBLOCADE® with a loading dose of 300 mg for the first two months. For maintenance, individuals can continue the 300 mg dose or decrease to the 100 mg dose.

Extended-release buprenorphine (brand name: Sublocade) is an extended-release formulation of buprenorphine that is administered monthly (at least every 26 days) via abdominal subcutaneous …

What do I need to know before starting treatment? • You will need to take a different form of buprenorphine for at least 7 days before starting buprenorphine injections. • Do NOT take other …

ly 16-24 mg/day of sublingual buprenorphine. According to the package insert, patients should be treated with a transmucosal formulation of buprenorphine for at least 7 days and on stable doses of …